1 completed, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow ICE protocol 5: new trials by email Literature Review of ICE protocol 5 trials Research Report on ICE protocol 5
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma Selinexor, ICE Chemotherapy - Peripheral T-cell Lymphoma | Phase 1 | Completed | National Cancer Centre, Singapore | 11 | 2016-07-01 | 2021-04-28 |
| Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors Bevacizumab, ICE chemotherapy regimen - Germ Cell Tumor | Phase 1 / Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 30 | 2012-04-01 | 2019-02-19 |
Lymphoma, T-Cell, Peripheral (1) · Neoplasms, Germ Cell and Embryonal (1)
Assistance Publique - Hôpitaux de Paris (1) · National Cancer Centre, Singapore (1)
France (1) · Singapore (1)
Tiffany PL Tang (1)